Viral hepatitis, IBD co-morbidity

IBD_VIRAL_HEPATITIS

animal viral hepatitis: A hepatitis that involves viral infection of an animal causing inflammation of the liver.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints HEPATITIS_A HEPATITIS_B HEPATITIS_ACUTE_OTHER_VIRAL HEPATITIS_CHRONIC_VIRAL	2969
6. Filter based on genotype QC (FinnGen only)	2507

Control definitions (FinnGen only)

Control exclude: IBD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	IBD_VIRAL_HEPATITIS
CONTROL_EXCLUDE	IBD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	HEPATITIS_A\|HEPATITIS_B\|HEPATITIS_ACUTE_OTHER_VIRAL\|HEPATITIS_CHRONIC_VIRAL
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Viral hepatitis, IBD co-morbidity based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2507	1122	1385
Unadjusted period prevalence (%)	0.53	0.40	0.64
Median age at first event (years)	36.33	34.38	37.91

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2786: Matched controls
27858

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

168.6

322.0

159

F10.09

ICD-10 Finland

Alcohol intoxication UNS

21.6

321.6

244

123

N06AX21

ATC

duloxetine; oral

9.1

321.5

425

538

M79.6

ICD-10 Finland

Pain in limb

4.4

319.9

1252

4333

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

140.4

317.4

159

X59

ICD-10 Finland

Exposure to unspecified factor

5.3

315.2

794

1939

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

91.6

313.2

164

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

150.2

313.1

156

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

46.0

313.1

185

XF400

NOMESCO Finland

ECG with 12 standard connections

6.9

312.4

552

968

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

14.4

310.7

292

225

N05AF03

ATC

chlorprothixene; systemic

14.6

310.5

289

219

N05AA02

ATC

levomepromazine; systemic

20.4

307.7

467

272

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

52.5

307.7

218

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

374.0

307.7

441

F10.20

ICD-10 Finland

Alcohol dependence currently independent

26.1

307.7

308

132

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

10.5

307.7

639

770

A10AB05

ATC

insulin aspart; parenteral

75.5

307.7

177

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

36.5

307.7

219

T74.1

ICD-10 Finland

Physical abuse

21.5

307.7

301

156

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

53.9

307.7

438

N06AX11

ATC

mirtazapine; oral

6.6

307.7

1436

3882

B18.2

ICD-10 Finland

Chronic viral hepatitis C

15427.3

307.7

2051

Z72.2

ICD-10 Finland

Drug use

163.8

307.7

382

F32.9

ICD-10 Finland

Depressive episode, unspecified

7.4

307.7

795

1425

F10.24

ICD-10 Finland

Alcohol depence active use

26.1

307.7

242

101

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

277.3

307.7

383

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

260.4

307.7

302

E11

ICD-10 Finland

Type 2 diabetes mellitus

30.1

307.7

285

105

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

26.7

307.7

368

158

C07AA05

ATC

propranolol; systemic

5.7

307.7

952

2341

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

11.9

307.7

502

507

A10BK03

ATC

empagliflozin; oral

89.9

307.7

177

N05AH03

ATC

olanzapine; systemic

12.5

307.7

764

818

S06.0

ICD-10 Finland

Concussion

27.0

307.7

469

207

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

136.6

307.7

191

N07BB01

ATC

disulfiram; oral

16.3

307.7

553

417

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

289.0

307.7

459

N02BF01

ATC

gabapentin; oral

17.1

307.7

356

237

N05BA12

ATC

alprazolam; oral

10.2

307.7

652

811

P18

ICPC

Medication abuse

155.8

307.7

242

R56.8

ICD-10 Finland

Other and unspecified convulsions

20.4

307.7

361

202

P19

ICPC

Drug abuse

139.4

307.7

636

N03AG01

ATC

valproic acid; systemic, rectal

15.8

307.7

427

316

F10.25

ICD-10 Finland

Alcohol dependence continuous use

25.9

307.7

279

119

N06AB04

ATC

citalopram; systemic

6.5

307.7

921

1968

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

34.4

307.7

593

217

N05AX08

ATC

risperidone; systemic

9.1

307.7

516

682

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

16.4

307.7

289

195

215

Kela drug reimbursment

Diabetes, non-insulin-treated

645.0

307.7

483

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

17.5

307.7

777

601

T36

ICD-10 Finland

Poisoning by systemic antibiotics

34.8

307.7

722

277

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

83.2

307.7

406

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

318.9

307.7

361

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

165.5

307.7

171

N05BA02

ATC

chlordiazepoxide; systemic

24.9

307.7

254

112

N06AX16

ATC

venlafaxine; oral

7.1

307.7

706

1274

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

152.9

307.7

225

A46

ICD-10 Finland

Erysipelas

8.3

307.7

679

1038

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

141.4

307.7

441

N05AH04

ATC

quetiapine; oral

11.7

307.7

1292

1919

F60.2

ICD-10 Finland

Dissocial personality disorder

155.9

307.7

189

SPAT1265

SPAT

Breathalyser

36.4

307.7

206

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

27.8

307.7

249

AA1AD

NOMESCO Finland

CT of head and brain

11.9

307.7

920

1109

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

108.3

307.7

238

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

7.5

307.7

645

1078

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

18.7

307.7

273

161

N05CF01

ATC

zopiclone; oral

5.3

307.7

1094

3024

F29

ICD-10 Finland

Unspecified nonorganic psychosis

11.5

307.7

548

582

A10BA02

ATC

metformin; oral

30.6

307.7

496

196

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

41.5

307.7

314

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

196.4

307.7

234

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

49.8

307.7

233

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

425.1

307.7

547

N05BA04

ATC

oxazepam; oral

7.1

307.7

1236

2797

103

Kela drug reimbursment

Diabetes, insulin-treated

470.8

307.7

502

T90

ICPC

Diabetes non-insulin dependent

28.6

307.7

479

201

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.8

307.7

1425

4273

N03AE01

ATC

clonazepam; systemic

34.0

307.7

523

188

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

46.4

307.7

1424

614

A10AE04

ATC

insulin glargine; parenteral

134.3

307.7

234

N02AX02

ATC

tramadol; systemic, rectal

6.7

307.7

1324

3297

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

8.3

307.7

640

970

Z2446

NOMESCO Finland

Social worker

12.5

307.7

494

473

P15

ICPC

Chronic alcohol abuse

16.6

307.7

411

287

SPAT1272

SPAT

Drug screening

135.1

307.7

189

N03AX16

ATC

[U] pregabalin

12.4

307.7

792

863

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

31.3

307.7

335

121

N03AX12

ATC

[U] gabapentin; oral

24.0

307.7

564

291

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

7.3

307.7

567

943

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

17.1

307.7

392

264

Z3231

NOMESCO Finland

Registered nurse

5.3

307.7

1003

2661

N05CD07

ATC

temazepam; oral

16.1

307.7

650

517

N05BA01

ATC

diazepam; systemic, rectal

18.3

307.7

1036

872

N05BE01

ATC

buspirone; oral

16.7

307.7

280

185

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

819.2

304.2

294

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

75.2

302.9

163

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

5.0

302.6

826

2151

EBA00

NOMESCO Finland

Extraction of tooth

4.2

302.6

1468

5877

N06AB06

ATC

sertraline; oral

6.0

301.0

622

1269

Z3226

NOMESCO Finland

Physiotherapist

6.2

298.1

595

1174

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

7.3

294.6

480

771

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

46.9

292.6

172

NA1AD

NOMESCO Finland

Cervical spine CT examination

18.9

292.5

236

136

A49.9

ICD-10 Finland

Bacterial infection, unspecified

8.0

292.2

435

632

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

1559.7

291.7

279

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.3

291.3

562

1072

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

20.9

288.8

222

115

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

5.5

288.4

677

1546

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

44.4

287.1

171

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

391.1

286.9

284

N06AA12

ATC

doxepin; systemic

13.9

283.8

271

214

R4110

NOMESCO Finland

Physiotherapy

4.6

283.6

875

2500

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

6.1

281.5

567

1125

N06AB03

ATC

fluoxetine; oral

6.1

278.5

553

1082

N03AX09

ATC

lamotrigine; oral

11.1

277.5

310

312

C03CA01

ATC

furosemide; systemic

6.1

276.0

546

1064

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

25.8

274.7

193

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

419.7

271.3

268

A01

ICPC

Pain general/multiple sites

8.7

270.8

369

482

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

38.3

268.5

166

K04.5

ICD-10 Finland

Chronic apical periodontitis

4.1

268.4

1077

3716

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

361.8

266.6

265

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

409.2

264.8

262

M54.5

ICD-10 Finland

Low back pain

4.0

263.1

1073

3737

N05AX12

ATC

aripiprazole; systemic

8.1

262.4

379

530

F60.9

ICD-10 Finland

Personality disorder, unspecified

25.0

260.2

185

SPAT1254

SPAT

Administration of medicine

6.5

259.5

475

856

N05AD01

ATC

haloperidol; systemic

13.9

259.2

247

194

EBA30

NOMESCO Finland

Extraction of root of tooth

8.8

258.3

346

442

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

28.0

258.1

176

A06AD11

ATC

lactulose; oral

6.8

257.1

444

754

B17.1

ICD-10 Finland

Acute hepatitis C

+∞

255.2

241

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

11.4

254.4

277

268

TPH04

NOMESCO Finland

Cathetrisation of vein

4.8

253.8

712

1872

N02BF02

ATC

pregabalin; oral

12.8

252.0

252

214

J01FF01

ATC

clindamycin; systemic

4.2

250.6

917

2944

P16

ICPC

Acute alcohol abuse

16.6

248.6

213

138

A02BC02

ATC

pantoprazole; systemic

3.8

246.1

1802

9118

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

9.6

244.8

302

347

A28

ICPC

Limited function/disability NOS

7.8

243.1

362

523

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.6

243.1

1390

5998

L17

ICPC

Foot/toe symptom/complaint

4.1

241.8

887

2844

SPAT1227

SPAT

Substance abuse rehabilitation

41.6

241.5

146

G47.3

ICD-10 Finland

Sleep apnoea

7.3

240.1

380

587

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

4.1

239.0

864

2739

M48.0

ICD-10 Finland

Spinal stenosis

40.2

237.7

145

N06AB10

ATC

escitalopram; oral

4.1

237.6

874

2804

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

18.5

237.0

192

111

M54.4

ICD-10 Finland

Lumbago with sciatica

6.0

235.4

469

914

G56.0

ICD-10 Finland

Carpal tunnel syndrome

11.2

235.1

258

252

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

7.8

234.1

346

495

N05CF02

ATC

zolpidem; oral

4.6

234.1

674

1800

S18

ICPC

Laceration/cut

3.6

232.1

1283

5383

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.5

222.1

1164

4696

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

10.3

220.2

256

271

S97

ICPC

Chronic ulcer skin

13.2

218.7

214

175

F61.0

ICD-10 Finland

Mixed personality disorders

17.7

218.1

180

108

P29

ICPC

Psychological sympt/compl other

5.6

217.9

470

982

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

8.8

217.6

287

358

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.1

216.9

740

2234

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

20.9

214.9

164

WX892

NOMESCO Finland

Monitored bed care

7.9

214.6

314

443

N06AB05

ATC

paroxetine; oral

7.3

213.3

337

518

N03AF01

ATC

carbamazepine; oral, rectal

19.1

212.2

169

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

24.9

210.0

149

EBA05

NOMESCO Finland

Complicated extraction of tooth

3.7

209.6

916

3270

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

3.3

209.6

1590

7959

ZY010

NOMESCO Finland

Hospital outpatient

7.4

209.2

324

487

L28

ICPC

Limited function/disability (L)

6.9

208.4

348

567

K08.3

ICD-10 Finland

Retained dental root

6.3

206.1

376

670

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

18.8

205.9

165

IFC01, ,

SPAT

319.6

205.3

206

EBA15

NOMESCO Finland

Extraction of multiple teeth

10.5

204.8

233

239

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

28.8

203.4

137

F20.9

ICD-10 Finland

Schizophrenia, unspecified

9.4

203.2

253

293

WX110

NOMESCO Finland

Infiltration anesthesia

4.2

201.6

2269

14311

A10BK01

ATC

dapagliflozin; oral

64.2

201.1

111

M54.9

ICD-10 Finland

Dorsalgia, unspecified

6.0

200.8

386

723

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

79.4

200.4

107

Z71.8

ICD-10 Finland

Other specified counselling

3.3

199.6

1178

5048

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

9.9

199.4

237

258

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

7.2

198.9

313

478

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

521.3

198.2

195

ZY000

NOMESCO Finland

Hospital inpatient

15.8

197.8

173

116

A41.9

ICD-10 Finland

Sepsis, unspecified

16.5

196.4

168

108

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

7.1

196.4

315

491

IBZ15, ,

SPAT

89.1

195.9

103

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

8.8

194.9

256

317

S10

ICPC

Boil/carbuncle

7.2

194.8

310

479

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

7.4

193.6

298

444

ZXE10

NOMESCO Finland

More than one and less than three hours

3.5

192.7

934

3537

K05.31

ICD-10 Finland

Periodontitis pronounced

5.4

192.1

426

908

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

11.2

191.7

208

199

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

6.9

191.4

314

501

Z2221

NOMESCO Finland

Medical doctor

3.4

190.1

947

3643

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

9.4

189.2

235

271

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

7.7

188.8

279

397

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

8.6

187.4

251

318

M25.5

ICD-10 Finland

Pain in joint

3.6

186.5

782

2692

L12

ICPC

Hand/finger symptom/complaint

4.2

185.7

593

1691

N05AH02

ATC

clozapine; systemic

8.8

184.9

242

298

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

5.2

184.5

424

931

R02

ICPC

Shortness of breath/dyspnoea

5.4

183.9

399

833

N05AB01

ATC

dixyrazine; systemic

29.2

183.7

123

R4120

NOMESCO Finland

Occupational therapy

10.6

183.7

207

209

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

3.2

183.7

1789

10074

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

7.5

182.3

274

397

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

3.3

181.5

1021

4209

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

23.0

180.7

132

T89

ICPC

Diabetes insulin dependent

97.2

180.6

S76

ICPC

Skin infection other

8.5

179.8

243

311

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

10.0

179.4

211

226

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

5.2

178.8

412

906

L03

ICPC

Low back symptom/complaint

3.5

178.4

825

3014

Z76.0

ICD-10 Finland

Issue of repeat prescription

3.3

178.0

977

3962

D72

ICPC

Viral hepatitis

369.9

175.5

175

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.1

175.0

1070

4613

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

5.4

174.9

383

805

N03AF02

ATC

oxcarbazepine; oral

69.4

172.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

6.2

172.0

318

571

ZXD05

NOMESCO Finland

Urgent procedure

3.2

171.4

964

3952

-1, ,

NOMESCO Finland

3.0

171.0

1210

5649

IGV01

NOMESCO Finland

Psychiatric network contact

16.1

170.2

147

M17.1

ICD-10 Finland

Other primary gonarthrosis

8.5

168.7

226

286

ZXA05

NOMESCO Finland

Left side

4.1

168.1

552

1598

Y07

ICD-10 Finland

Other maltreatment

23.4

166.7

121

S01.0

ICD-10 Finland

Open wound of scalp

5.7

166.6

339

666

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

9.1

165.8

209

245

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

6.3

165.2

298

522

WYA30, ,

SPAT

44.1

164.6

ZXD35

NOMESCO Finland

Usual procedure

11.0

164.5

180

174

R50.9

ICD-10 Finland

Fever, unspecified

4.1

164.3

532

1523

IBZ14, ,

SPAT

55.9

162.6

N05CD08

ATC

midazolam; nasal, systemic

23.2

162.1

118

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

13.1

161.8

157

126

ZXA00

NOMESCO Finland

Right side

3.9

161.6

555

1656

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

342.8

159.7

160

N06AX12

ATC

bupropion; oral

5.0

159.5

377

844

N02BE01

ATC

paracetamol; systemic, rectal

4.0

159.1

2382

16570

TKC20

NOMESCO Finland

Catheterisation of bladder

7.8

158.7

229

316

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

6.5

158.7

274

459

N06AA09

ATC

amitriptyline; systemic

8.9

158.2

204

246

WX002

NOMESCO Finland

Sedation and analgesia

4.1

157.9

497

1392

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

7.3

157.6

241

355

NE1AA

NOMESCO Finland

Pelvis X-ray examination

13.0

157.6

154

125

WX408

NOMESCO Finland

General anesthesy, balanced

3.4

157.2

721

2598

R5140

NOMESCO Finland

Monitoring the use of the aid

13.6

157.1

149

115

O35.5

ICD-10 Finland

Maternal care for (suspected) damage to fetus by drugs

78.7

157.0

P99

ICPC

Psychological disorders other

7.7

156.9

230

323

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

49.5

156.9

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.8

156.8

575

1792

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

25.4

156.6

110

P74

ICPC

Anxiety disorder/anxiety state

6.2

156.6

285

503

Z72.1

ICD-10 Finland

Alcohol use

17.2

156.1

130

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

9.6

154.9

187

207

A02BC01

ATC

omeprazole; systemic

3.5

154.1

669

2326

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

275.6

154.1

156

K02.1

ICD-10 Finland

Caries of dentine

3.0

154.0

1976

12432

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

13.9

153.6

144

109

IGY02

NOMESCO Finland

Psychiatric monitoring contact

7.3

153.3

236

350

R51.80

ICD-10 Finland

Headache

4.4

153.2

434

1122

N06AX03

ATC

mianserin; oral

9.4

153.0

188

213

SPAT1262

SPAT

Handing over of treatment supplies

6.4

152.1

266

451

IHZ04, ,

SPAT

12.1

151.7

155

135

R06.0

ICD-10 Finland

Dyspnoea

3.5

151.4

624

2097

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

4.3

150.5

439

1160

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

205.0

150.4

155

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

10.1

149.6

174

183

ZXE00

NOMESCO Finland

One hour or less

2.9

149.5

1082

5037

V03AA01, ,

ATC

18.0

148.7

121

WX290

NOMESCO Finland

Other blockage of nerve

2.8

147.1

1678

9833

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.7

146.8

542

1692

K04.0

ICD-10 Finland

Pulpitis

4.1

146.7

464

1300

C07AB07

ATC

bisoprolol; oral

3.0

146.6

916

3932

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.9

146.5

503

1494

R52.2

ICD-10 Finland

Other chronic pain

16.3

146.1

125

N05AB03

ATC

perphenazine; systemic, rectal

7.3

145.4

222

326

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

4.3

145.2

423

1115

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

9.0

145.1

184

217

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

5.7

145.0

287

548

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

12.8

144.6

142

116

A10BH01

ATC

sitagliptin; oral

740.5

144.3

141

NF1AA

NOMESCO Finland

Hip X-ray examination

15.2

144.0

128

F90.0

ICD-10 Finland

Disturbance of activity and attention

5.9

142.3

270

495

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

24.3

141.6

101

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

11.4

141.5

150

138

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

12.5

141.4

141

118

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

6.5

140.0

240

398

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

17.7

139.0

114

L03.9

ICD-10 Finland

Cellulitis, unspecified

12.5

138.9

139

117

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

20.2

138.8

107

N05AN01

ATC

lithium; oral

9.5

138.7

169

189

SAA01

NOMESCO Finland

Simple examination of mouth

3.2

138.5

2226

15378

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

26.1

138.2

P01AB01

ATC

metronidazole; oral, rectal

2.7

137.9

1101

5349

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

14.7

137.1

124

K04.7

ICD-10 Finland

Periapical abscess without sinus

5.1

136.3

306

653

N04AA02

ATC

biperiden; systemic

10.8

136.2

150

146

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

354.0

135.9

136

A10AC01

ATC

insulin (human); parenteral

16.0

135.6

117

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

19.8

135.1

105

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

19.3

134.7

106

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

36.1

134.0

R11

ICD-10 Finland

Nausea and vomiting

5.2

133.9

294

615

N05AD03

ATC

melperone; systemic

23.3

133.8

TPH07

NOMESCO Finland

Cathetrisation of artery

4.8

133.4

327

751

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

38.4

133.1

Y09

ICD-10 Finland

Assault by unspecified means

33.7

133.0

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

17.0

132.6

111

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

11.7

132.2

138

124

N05BA06

ATC

lorazepam; systemic, sublingual

6.8

132.2

217

344

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

55.0

132.1

R05

ICPC

Cough

3.1

131.8

723

2864

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

674.2

131.7

129

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

7.6

131.0

192

269

F05.9

ICD-10 Finland

Delirium, unspecified

21.6

130.9

SPAT1260

SPAT

Consultation of another employee

3.8

130.8

462

1393

W19

ICD-10 Finland

Unspecified fall

4.9

130.6

312

701

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

48.8

130.6

X57

ICD-10 Finland

Unspecified privation

11.7

129.5

135

121

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

7.7

129.2

188

261

A97

ICPC

No disease

3.2

129.2

652

2459

J01DB01

ATC

cefalexin; oral

3.4

128.9

2329

16787

N05AA01

ATC

chlorpromazine; systemic, rectal

12.4

128.5

129

109

P06

ICPC

Sleep disturbance

4.0

128.1

412

1163

F51.0

ICD-10 Finland

Nonorganic insomnia

3.2

127.2

638

2396

A03

ICPC

Fever

3.1

126.9

664

2555

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

39.6

125.9

L86

ICPC

Back syndrome with radiating pain

8.3

125.5

170

217

IFC99

NOMESCO Finland

Other biological psychiatric intervention

56.0

125.4

R52.9

ICD-10 Finland

Pain, unspecified

4.6

125.2

324

776

JN3AD

NOMESCO Finland

Abdominal CT examination

4.0

125.2

391

1080

WVA20, ,

SPAT

8.3

125.1

169

215

O98.4

ICD-10 Finland

Viral hepatitis complicating pregnancy, childbirth and the puerperium

1252.4

123.9

120

IGY02, ,

SPAT

10.0

123.9

144

151

ACC51

NOMESCO Finland

Release of median nerve

221.6

123.8

127

SPAT1240

SPAT

Therapeutic discussion

3.8

123.7

424

1250

R60.0

ICD-10 Finland

Localized oedema

5.0

123.4

288

634

N06BA04

ATC

methylphenidate; oral

5.9

123.3

232

421

0709X

ICD-9 Finland

Viral hepatitis, Unspecified viral hepatitis without mention of hepatic coma

+∞

122.8

117

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

122.8

117

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

324.3

122.3

123

X99.9

ICD-10 Finland

Assault by sharp object by unknown person

46.2

122.2

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

22.9

122.0

D10

ICPC

Vomiting

4.5

121.5

318

768

D11

ICPC

Diarrhoea

3.6

121.0

458

1442

ZXD10

NOMESCO Finland

Scheduled procedure

2.7

121.0

898

4155

SPAT1301

SPAT

No procedures

2.9

120.6

730

3037

P01

ICPC

Feeling anxious/nervous/tense

3.2

120.3

560

2007

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.4

119.8

494

1643

M13.9

ICD-10 Finland

Arthritis, unspecified

9.9

119.7

140

148

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

21.9

119.6

F41.09

ICD-10 Finland

UNS Panic Syndrome

7.2

119.0

182

267

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

10.3

118.9

135

137

T51.0

ICD-10 Finland

Toxic effect: Ethanol

22.1

118.9

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

3.4

118.8

499

1678

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

23.3

118.7

X78

ICD-10 Finland

Intentional self-harm by sharp object

19.8

118.4

K02.9

ICD-10 Finland

Dental caries, unspecified

10.5

118.1

132

131

ZXE20

NOMESCO Finland

More than three and less than five hours

4.1

118.1

365

999

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

6.0

118.0

219

392

R07.4

ICD-10 Finland

Chest pain, unspecified

3.0

117.9

648

2553

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

12.7

117.8

116

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

6.5

117.2

199

326

G40.9

ICD-10 Finland

Epilepsy, unspecified

597.5

116.9

115

Z72.0

ICD-10 Finland

Tobacco use

9.0

116.9

147

171

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

5.4

116.9

244

487

X58

ICD-10 Finland

Exposure to other specified factors

3.3

116.7

509

1751

N06AA06

ATC

trimipramine; systemic

11.7

116.3

121

108

J01CF05

ATC

flucloxacillin; systemic

4.7

116.1

285

653

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

23.4

116.0

M03BC01

ATC

orphenadrine (citrate); systemic

3.1

116.0

585

2194

N07BA03

ATC

varenicline; oral

5.6

115.7

233

450

Z2445

NOMESCO Finland

Psychologist

6.9

115.4

183

279

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

33.0

115.1

M16.1

ICD-10 Finland

Other primary coxarthrosis

16.3

115.0

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

22.8

114.8

N01

ICPC

Headache

3.9

114.7

376

1072

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

39.9

114.7

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.8

114.6

221

410

XCK10

NOMESCO Finland

Photography of fundus of eye

6.6

114.3

192

311

SPE90

NOMESCO Finland

Other partial denture

15.4

113.9

100

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.5

113.5

232

454

B16.9

ICD-10 Finland

Acute hepatitis B without delta-agent and without hepatic coma

1143.6

113.4

110

K92.0

ICD-10 Finland

Haematemesis

10.7

113.1

125

122

F99

ICD-10 Finland

Mental disorder, not otherwise specified

8.5

112.4

149

185

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

19.3

112.1

P72

ICPC

Schizophrenia

6.7

112.1

184

291

N05CD02

ATC

nitrazepam; oral

24.2

112.0

A02BC03

ATC

lansoprazole; oral

3.0

111.2

603

2351

N02AJ06

ATC

codeine and paracetamol; systemic

2.6

111.1

970

4824

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

47.5

111.0

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

16.8

110.9

L15

ICPC

Knee symptom/complaint

3.1

110.8

540

1981

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

235.4

110.5

113

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

4.3

110.3

309

785

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

22.5

110.3

N02AA05

ATC

oxycodone; systemic

4.0

110.2

345

951

M01AE03

ATC

ketoprofen; systemic, rectal

2.7

109.9

806

3680

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

10.3

109.9

125

127

SPAT1247

SPAT

Outpatient detoxication and monitoring

26.0

109.3

IEV99

NOMESCO Finland

Other psychiatric network intervention

20.1

109.0

F43.1

ICD-10 Finland

Post-traumatic stress disorder

8.0

108.9

151

198

C03DA01

ATC

spironolactone; oral

4.9

108.5

257

571

F39

ICD-10 Finland

Unspecified mood [affective] disorder

8.5

108.2

143

177

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

284.5

107.7

109

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

6.9

107.3

171

262

Z3229

NOMESCO Finland

Other healthcare associate professional

5.3

107.2

227

458

WX730

NOMESCO Finland

Conventional respirator

15.7

107.1

SGA01

NOMESCO Finland

Emergency treatment

2.9

107.0

642

2640

RS220, ,

NOMESCO Finland

14.3

106.9

S29

ICPC

Skin symptom/complaint other

3.0

106.6

583

2279

SPAT1222

SPAT

Counselling/guidance promoting independent living

4.3

106.4

302

774

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

7.4

106.0

158

225

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.6

105.6

883

4284

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.7

105.6

257

584

XA800

NOMESCO Finland

Neuropsychological investigation

13.0

105.5

102

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

4.5

105.2

274

657

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

9.3

104.9

128

143

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

104.8

100

N05AF05

ATC

zuclopenthixol; systemic

11.8

104.7

108

Z35.7

ICD-10 Finland

Supervision of high-risk pregnancy due to social problems

31.7

104.5

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

5.2

104.3

227

469

J01MA12

ATC

levofloxacin; systemic

3.3

104.3

450

1531

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

17.4

104.2

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.9

103.9

575

2260

K59.09

ICD-10 Finland

Constipation, unspecified

6.3

103.5

181

305

SFA30

NOMESCO Finland

Three-surface restoration

2.4

103.5

1235

7020

C08CA01

ATC

amlodipine; oral

2.7

103.5

682

2940

K10.3

ICD-10 Finland

Alveolitis of jaws

5.4

103.1

211

413

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.2

102.5

482

1726

R41.0

ICD-10 Finland

Disorientation, unspecified

17.2

102.4

QCA10

NOMESCO Finland

Incision of skin of upper limb

47.1

102.2

R74

ICPC

Upper respiratory infection acute

2.4

101.7

1134

6248

N06AX05

ATC

trazodone; oral

10.5

101.1

113

112

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

20.0

101.1

N06AA10

ATC

nortriptyline; systemic

25.1

100.8

G56.2

ICD-10 Finland

Lesion of ulnar nerve

17.4

100.8

B15.9

ICD-10 Finland

Hepatitis A without hepatic coma

+∞

100.6

ZXY60

NOMESCO Finland

2-person team, nurses

18.7

100.5

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

9.9

100.3

117

123

X84

ICD-10 Finland

Intentional self-harm by unspecified means

46.3

100.2

SPAT1310

SPAT

Counselling related to known health issue

2.6

100.0

735

3339

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.2

99.9

286

737

N06CA01

ATC

amitriptyline and psycholeptics; systemic

5.2

99.5

216

445

SPAT1234

SPAT

Support of social functional capacity

7.5

99.1

145

202

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

178.2

98.9

103

M19.0

ICD-10 Finland

Primary arthrosis of other joints

8.6

98.1

127

153

N06AX26

ATC

vortioxetine; oral

4.0

98.0

301

816

KMAK, ,

NOMESCO Finland

2.3

97.4

1628

10577

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

51.9

97.4

SPAT1283

SPAT

Restricted health certificate

2.7

97.3

646

2786

A10AE05

ATC

insulin detemir; parenteral

207.3

97.1

100

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

40.2

96.8

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

133.6

96.7

103

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

96.4

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

253.8

96.3

G44.2

ICD-10 Finland

Tension-type headache

4.0

96.0

294

795

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

8.9

96.0

121

141

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

132.3

95.7

102

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

960.5

95.5

D01

ICPC

Abdominal pain/cramps general

3.5

95.2

374

1197

-50

ICPC

Medication/prescr/renewal

8.0

95.2

131

170

K04.08

ICD-10 Finland

Other specified pulpit

3.6

95.2

355

1099

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

11.8

95.1

SFA10

NOMESCO Finland

One-surface restoration

2.3

94.9

1624

10608

R53

ICD-10 Finland

Malaise and fatigue

2.7

94.8

641

2786

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

6.2

94.4

166

281

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

8.0

94.3

130

169

WZC00

NOMESCO Finland

Treatment plan or consultation

2.4

93.7

981

5219

Z01.8

ICD-10 Finland

Other specified special examinations

3.0

93.2

496

1899

F92.0

ICD-10 Finland

Depressive conduct disorder

38.8

92.7

B01AB05

ATC

enoxaparin; parenteral

2.7

92.0

604

2583

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

7.1

91.5

141

208

F20.0

ICD-10 Finland

Paranoid schizophrenia

12.3

91.1

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.8

90.9

173

316

Z01.2

ICD-10 Finland

Dental examination

2.2

90.7

1401

8723

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.8

90.6

173

317

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

7.3

90.6

135

192

J45.9

ICD-10 Finland

Asthma, unspecified

3.0

90.4

453

1675

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

316.0

90.3

P76

ICPC

Depressive disorder

4.0

90.2

271

722

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

21.1

90.2

SPAT1249

SPAT

Treatment-related counselling outside office

2.4

90.0

921

4837

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

13.0

89.9

A29

ICPC

General symptom/complaint other

3.5

89.5

342

1074

P17

ICPC

Tobacco abuse

12.8

89.2

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

27.1

89.0

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

10.0

88.8

102

105

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

21.8

88.7

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

9.6

88.4

105

113

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

27.8

88.4

N03AX14

ATC

levetiracetam; systemic

20.8

88.3

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

6.2

87.8

154

260

M79.1

ICD-10 Finland

Myalgia

3.3

87.5

373

1253

TAB00

NOMESCO Finland

Lumbar puncture

9.4

87.3

105

115

P01BA02

ATC

hydroxychloroquine; oral

13.3

87.2

OAB50, ,

SPAT

8.0

87.0

120

156

R03AC02

ATC

salbutamol; inhalant

2.2

86.9

1376

8605

B19.9

ICD-10 Finland

Unspecified viral hepatitis without hepatic coma

47.2

86.9

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

17.2

86.9

SPAT1263

SPAT

Sampling

2.3

86.7

976

5320

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

11.2

86.3

F31.8

ICD-10 Finland

Other bipolar affective disorders

8.8

86.2

110

130

SGA02

NOMESCO Finland

Opening and preparing the root canals

3.0

86.0

438

1632

JN5BD

NOMESCO Finland

Head and body CT examination for trauma

16.8

85.9

Z22.5

ICD-10 Finland

Carrier of viral hepatitis

435.7

85.5

N04BC05

ATC

pramipexole; oral

7.5

85.4

125

174

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

8.0

85.3

117

151

B17.8

ICD-10 Finland

Other specified acute viral hepatitis

853.8

85.0

K02.2

ICD-10 Finland

Caries of cementum

5.6

85.0

165

307

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

10.9

84.9

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

5.8

84.9

159

286

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

224.4

84.9

Z29

ICPC

Social problem NOS

8.2

84.7

114

144

ZZA00

NOMESCO Finland

Split skin graft

9.9

84.6

102

K04.1

ICD-10 Finland

Necrosis of pulp

3.0

84.3

415

1516

Z02.7

ICD-10 Finland

Issue of medical certificate

4.2

84.3

242

623

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

5.0

84.3

187

392

S22.3

ICD-10 Finland

Fracture of rib

4.5

84.2

215

506

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

19.3

84.2

Z03

ICPC

Housing/neighbourhood problem

21.5

84.2

A04

ICPC

Weakness/tiredness general

3.1

83.7

393

1397

Z00.0

ICD-10 Finland

General medical examination

2.8

83.7

514

2116

D64.9

ICD-10 Finland

Anaemia, unspecified

4.4

83.5

222

539

J01DA01

ATC

[U] cefalexin

2.2

83.3

1578

10518

A02BC05

ATC

esomeprazole; systemic

2.3

83.0

886

4708

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.1

82.9

388

1376

A10BJ06

ATC

semaglutide; parenteral

+∞

82.7

SPAT1216

SPAT

Assessment of functional ability

4.3

82.6

224

552

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.5

82.4

679

3221

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

8.8

82.3

105

124

SPAT1215

SPAT

Assessment of need for medical rehabilitation

7.1

82.0

125

182

SPA47

NOMESCO Finland

Precision impression for denture

8.2

82.0

111

141

XF600

NOMESCO Finland

Bloodpressure measurement

5.6

82.0

160

299

WX872

NOMESCO Finland

Intensive care

5.6

81.8

159

296

ZYC01

NOMESCO Finland

Remote contact by phone

4.7

81.6

199

451

RS221, ,

NOMESCO Finland

16.4

81.5

R44.0

ICD-10 Finland

Auditory hallucinations

28.0

81.2

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

14.7

81.1

OAB43, ,

SPAT

0.4

81.1

474

9745

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

4.2

81.0

228

578

A08

ICPC

Swelling

6.8

80.5

128

195

R5110, ,

SPAT

6.4

80.4

136

221

IGY99

NOMESCO Finland

Other psychiatric treatment contact

7.0

80.4

125

186

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

101.0

80.4

WX203

NOMESCO Finland

Infraclavicular plexus blockade

9.2

79.9

110

TK800

NOMESCO Finland

Hemodialysis

12.5

79.8

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

800.7

79.8

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

5.7

79.7

154

285

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

21.1

79.6

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

7.6

79.5

114

155

WX110, ,

SPAT

3.8

79.4

265

759

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

605

1145

6.47

317.55

2.2

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

592

1097

6.58

317.43

2.2

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

707

1558

5.74

315.54

3.3

2.4

30.91

44.51

u/l

2.77

621

1366

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

735

1677

5.59

315.52

2.2

1.6

—

(3018095) Leukocytes [#/volume] in Urine

1411

5382

4.29

314.10

4.5

2.6

58.96

87.91

e6/l

0.87

956

3363

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1400

5322

4.28

312.86

2.2

1.6

95.99

95.87

pmol/l

0.03

762

2973

(3024354) Oxygen [Partial pressure] in Venous blood

484

738

7.73

312.23

4.0

2.4

5.12

4.71

kpa

2.79

461

719

(3012544) pH of Venous blood

587

945

7.60

307.65

4.5

2.8

7.37

7.38

3.53

346

497

(44816559) Phosphatidylethanol [Mass/volume] in Blood

756

827

12.17

307.65

2.9

1.7

0.26

0.28

mg/l

0.24

424

402

(3022096) Basophils/Leukocytes in Blood

1900

7342

5.99

307.65

9.6

5.3

0.67

0.69

0.80

1830

6912

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1003

211.21

307.65

2.3

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

1547

3965

7.52

307.65

7.1

3.4

88.51

92.60

8.34

1507

3895

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1671

5863

5.62

307.65

10.1

5.3

1.20

1.21

mmol/l

11.71

1493

5054

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1581

5122

5.82

307.65

9.5

5.0

1.20

1.21

mmol/l

5.97

1499

4749

(3037522) Nuclear Ab [Titer] in Serum

758

1484

6.64

307.65

1.4

1.2

242.98

364.88

titre

1.76

161

213

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1132

2631

6.56

307.65

3.1

1.6

388.03

213.47

u/l

2.86

1085

2500

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2306

7729

12.51

307.65

9.6

6.8

12.84

12.26

umol/l

0.73

2234

7396

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1010

1987

7.40

307.65

2.0

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2538

12497

12.58

307.65

13.1

6.7

84.83

76.11

u/l

15.42

2482

11839

(3001604) Monocytes [#/volume] in Blood

2008

7969

6.44

307.65

10.0

5.2

0.59

0.56

e9/l

5.35

1769

6814

(3018418) pH of Serum or Plasma

1162

3328

5.27

307.65

4.7

3.6

7.40

0.51

813

2175

(3005719) IgG [Mass/volume] in Serum or Plasma

548

863

7.66

307.65

2.2

2.6

13.01

11.04

g/l

11.73

523

808

(3042936) Bacteria identified in Isolate by Culture

774

1634

6.17

307.65

2.7

1.6

—

(3042517) Benzodiazepines panel - Urine

178

146.19

307.65

5.6

4.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1680

4469

7.95

307.65

2.4

1.7

—

(3032080) INR in Blood by Coagulation assay

1679

5209

6.59

307.65

10.0

8.2

1.13

1.16

inr

2.07

1366

4265

(3017143) Hepatitis C virus Ab [Presence] in Serum

1354

2887

8.18

307.65

2.1

1.7

—

(3002582) Erythrocytes [#/volume] in Urine

1272

4294

4.61

307.65

3.6

2.3

79.58

82.93

e6/l

0.03

936

2977

(3006315) Basophils [#/volume] in Blood

2013

7978

6.49

307.65

10.0

5.2

0.04

e9/l

2.27

1771

6821

(3019198) Lymphocytes [#/volume] in Blood

2026

8248

6.34

307.65

10.1

5.2

2.07

1.93

e9/l

3.77

1807

7240

(3002030) Lymphocytes/Leukocytes in Blood

1924

7755

5.79

307.65

9.7

5.2

30.06

29.27

2.06

1865

7389

(3009508) Creatinine [Moles/volume] in Urine

1474

3252

8.50

307.65

11.0

1.8

7.05

9.33

mmol/l

37.27

1325

2901

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1278

4307

4.63

307.65

4.2

2.3

56.03

76.54

u/l

0.88

1181

4036

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2089

5832

11.32

307.65

6.5

3.1

58.69

33.61

u/l

11.46

1993

5584

(3023183) Ammonium ion [Moles/volume] in Plasma

325

208

17.56

307.65

3.3

2.8

37.38

38.94

umol/l

0.31

303

199

(3013650) Neutrophils [#/volume] in Blood by Automated count

2139

9380

6.51

307.65

17.9

9.8

4.02

3.93

e9/l

0.88

1918

8024

(3021447) Carbon dioxide [Partial pressure] in Venous blood

588

919

7.84

307.65

4.6

2.7

5.88

5.80

kpa

0.82

564

899

(40758558) Short blood count panel - Blood

1359

4627

4.78

307.65

9.8

6.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

404

342

13.65

307.65

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

977

1003

14.46

307.65

16.2

2.0

—

(4198724) Urine methamphetamine measurement

321

112

32.26

307.65

6.1

2.2

—

(3019069) Monocytes/Leukocytes in Blood

1917

7355

6.15

307.65

9.6

5.4

8.54

8.76

2.79

1849

6949

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

917

1216

10.75

307.65

2.9

2.4

0.20

0.22

g/l

16.45

841

1162

(3003458) Phosphate [Moles/volume] in Serum or Plasma

678

1302

6.56

307.65

8.2

5.3

1.03

1.01

mmol/l

0.98

655

1219

(3013826) Glucose [Moles/volume] in Serum or Plasma

1956

8112

5.74

307.65

8.6

3.6

6.61

6.05

mmol/l

16.84

1875

7423

(3013115) Eosinophils [#/volume] in Blood

2047

8341

6.48

307.65

11.2

5.6

0.18

0.19

e9/l

0.37

1813

7256

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

632

1113

7.05

307.65

4.9

2.3

—

(3030467) Casts [#/volume] in Urine by Automated count

1173

3692

4.76

307.65

3.5

2.3

0.58

0.48

e6/l

0.43

836

2372

(3002032) Base excess in Venous blood by calculation

577

908

7.75

307.65

4.6

2.7

1.43

1.92

mmol/l

1.92

493

788

(3023368) Bacteria identified in Blood by Culture

1269

3154

6.55

307.65

7.7

3.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

580

896

7.91

307.65

1.6

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2021

5878

9.88

307.65

6.7

5.1

35.97

36.95

g/l

9.41

1941

5558

(3006504) Eosinophils/Leukocytes in Blood

1908

7346

6.07

307.65

9.5

5.3

2.69

2.90

4.30

1837

6936

(3016650) Hepatitis A virus Ab [Presence] in Serum

425

342

14.48

307.65

1.3

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

491

620

9.40

307.65

1.5

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1723

5743

6.24

307.65

3.0

2.0

—

(3018010) Neutrophils/Leukocytes in Blood

1904

7581

5.77

307.65

9.5

5.1

55.14

56.12

2.80

1849

7281

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1362

3196

7.38

307.65

3.4

1.6

1.66

1.31

52.06

1224

2946

(3021589) Normoblasts [#/volume] in Blood

1806

7532

4.97

307.65

15.3

7.6

0.00

e9/l

0.37

1503

6009

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

815

1822

5.91

307.65

3.6

2.8

13.29

9.41

umol/l

2.36

685

1647

(3007566) Smooth muscle Ab [Titer] in Serum

501

466

12.89

307.65

1.2

1.5

88.64

96.88

titre

0.17

(3014111) Lactate [Moles/volume] in Serum or Plasma

549

994

6.63

300.46

10.9

6.6

1.42

1.28

mmol/l

1.57

544

976

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

256

165

16.98

300.25

7.9

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

468

720

7.61

299.00

1.4

1.9

1.63

1.30

g/l

3.61

440

668

(3003396) Base excess in Arterial blood by calculation

566

1073

6.36

295.44

11.4

7.6

0.81

0.49

mmol/l

0.83

488

886

(3000991) Gas panel - Venous blood

538

975

6.60

293.85

12.0

7.3

—

(3019977) pH of Arterial blood

564

1083

6.28

290.27

11.6

7.6

7.41

7.42

2.94

269

495

(3027801) Oxygen [Partial pressure] in Arterial blood

559

1076

6.25

286.80

11.6

7.7

11.68

14.24

kpa

20.00

546

1035

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

559

1077

6.24

286.51

11.6

7.7

5.29

5.06

kpa

5.20

545

1034

(3007853) Bacteria identified in Skin by Aerobe culture

648

1451

5.52

281.89

2.2

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

763

1980

4.93

278.63

4.1

3.6

0.80

0.83

mmol/l

8.20

723

1895

(3012516) Albumin [Mass/volume] in Urine

807

2253

4.63

267.86

3.7

1.8

101.10

47.25

mg/l

3.74

531

1195

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

230

151

16.51

266.78

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

814

2327

4.53

261.40

4.5

2.0

21.12

8.47

mg/mmol

3.27

522

1226

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2119

11665

4.41

261.05

4.5

2.3

12.92

8.29

mm/h

34.80

1988

10907

(3021960) Folate [Moles/volume] in Serum or Plasma

935

2976

4.22

259.73

1.8

1.4

18.42

19.51

nmol/l

1.73

856

2629

(3015736) pH of Urine

1522

6766

3.75

257.93

5.8

2.2

6.29

6.16

4.51

816

3972

(3016502) Oxygen saturation in Arterial blood

496

941

6.20

257.00

12.3

8.2

95.25

96.64

4.34

487

903

(3018677) aPTT in Platelet poor plasma by Coagulation assay

646

1555

5.11

256.76

2.6

2.2

30.31

29.92

0.62

633

1522

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

803

2313

4.47

254.66

2.9

2.2

1.92

1.23

e6/l

0.54

373

1020

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

265

242

12.00

252.98

2.2

1.9

604.72

419.20

ug/l

0.45

254

230

(3031040) Bacteria [#/volume] in Urine by Automated count

1977

10561

4.00

249.86

5.2

2.8

401.23

489.50

e6/l

0.10

120

(3020191) Ethanol [Moles/volume] in Serum or Plasma

195

106

19.70

247.87

2.0

1.2

1.29

1.53

promille

0.68

152

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

644

1602

4.93

245.23

2.7

1.9

22.45

25.94

5.46

603

1501

(3004789) Transferrin [Mass/volume] in Serum or Plasma

677

1764

4.75

243.28

2.7

1.8

2.41

2.40

g/l

0.14

625

1633

(3026782) Osmolality of Urine

786

2315

4.34

240.66

3.2

2.0

520.40

558.10

mosm/kgh2o

3.90

695

1994

(3002173) Hemoglobin [Mass/volume] in Arterial blood

477

932

5.97

238.87

12.7

8.3

121.22

123.04

g/l

0.88

471

902

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

767

2230

4.37

238.77

3.1

2.2

3.73

2.34

e6/l

1.78

341

937

(3000850) Epithelial cells [#/volume] in Urine

834

2582

4.18

238.33

2.9

1.9

12.00

6.04

e6/l

1.82

764

2290

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

931

3140

3.95

235.33

2.6

1.9

2.82

2.53

mg/l

2.62

816

2693

(3022948) Iron [Moles/volume] in Serum or Plasma

695

1951

4.41

225.55

2.7

1.9

13.45

15.30

umol/l

6.18

651

1837

(3020779) Urea [Moles/volume] in Serum or Plasma

457

919

5.75

221.16

9.0

5.4

8.44

7.68

mmol/l

1.42

442

887

(3037467) Urinalysis macro (dipstick) panel - Urine

1993

11293

3.69

216.51

5.2

2.8

—

3.59

—

(3019309) Folate [Moles/volume] in Red Blood Cells

551

1336

4.89

214.65

1.8

1.5

1104.15

1084.62

nmol/l

0.17

415

1001

(3006922) Hepatitis E virus Ab [Presence] in Serum

199

158

13.49

206.88

1.2

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

354

592

6.70

206.64

13.6

9.5

24.34

24.23

mmol/l

0.20

348

581

(3026008) Bacteria identified in Urine by Culture

885

3154

3.65

202.07

3.6

2.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1119

4638

3.36

200.59

3.5

4.3

2.35

mmol/l

1.21

1012

4323

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

329

546

6.70

193.13

2.1

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

192

169

12.13

187.00

6.1

8.7

356.29

401.75

umol/l

2.69

168

151

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

710

2312

3.78

183.87

4.1

2.7

236.93

920.92

ng/l

5.56

472

1573

(3019150) Specific gravity of Urine by Refractometry

917

3587

3.32

177.35

7.1

2.2

1.02

kg/l

7.01

618

2099

(3044640) Blood type and Crossmatch panel - Blood

1125

4965

3.12

176.99

3.2

2.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

114

31.24

174.15

2.3

1.5

137.40

155.06

umol/l

0.10

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2402

16502

4.30

170.70

7.7

2.5

68.21

38.78

u/l

28.79

2335

15933

(3027945) Reticulocytes/Erythrocytes in Blood

449

1105

4.65

169.64

2.8

2.7

1.89

1.64

3.02

399

1007

(3019550) Sodium [Moles/volume] in Serum or Plasma

2652

19749

8.13

166.41

29.3

8.3

138.92

139.84

mmol/l

68.52

2620

19152

(3023103) Potassium [Moles/volume] in Serum or Plasma

2656

19879

8.20

163.73

29.3

8.3

3.96

3.94

mmol/l

3.40

2623

19203

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

157

124

13.36

163.36

1.8

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

788

2938

3.35

163.19

2.2

1.5

1.43

1.20

mg/l

0.48

620

2125

(3007164) IgA [Mass/volume] in Serum or Plasma

854

3383

3.20

159.33

1.5

1.3

2.58

2.28

g/l

4.59

572

2347

(3004119) Hemoglobin [Mass/volume] in Venous blood

303

561

5.94

158.46

4.2

2.6

130.23

134.06

g/l

1.52

294

549

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

205

252

8.70

156.49

32.0

22.7

1372.04

5148.88

nmol/l

0.50

198

243

(3021601) Nitrite [Presence] in Urine by Test strip

1532

8499

2.78

150.97

4.1

2.3

0.00

estimate

0.50

339

1513

(3035350) Ketones [Presence] in Urine by Test strip

1540

8575

2.78

150.51

4.1

2.3

7.84

0.90

estimate

0.66

344

1496

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

378

897

4.72

148.64

1.4

1.3

170.61

219.46

miu/ml

1.39

117

443

(3009261) Glucose [Presence] in Urine by Test strip

1545

8662

2.76

148.22

4.1

2.3

0.00

estimate

-0.00

324

1485

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

890

3745

3.02

147.86

3.1

2.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2129

14117

3.15

147.61

4.7

3.1

14.54

14.34

pmol/l

3.38

1985

13176

(3044889) 12 lead EKG panel

1928

12143

2.91

146.59

4.2

2.6

—

20734.73

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

999

4507

2.90

145.73

4.4

2.1

50.57

86.92

ng/l

0.61

648

2152

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

566

1828

3.63

145.56

1.4

1.1

31.49

12.98

iu/ml

6.06

202

472

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

658

2348

3.36

144.56

3.0

3.7

2.44

2.43

mmol/l

2.29

575

2116

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2455

17833

4.17

144.10

6.0

3.5

1.75

1.82

mu/l

2.04

2322

16768

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

224

337

7.14

143.46

3.6

3.0

5.34

5.04

kpa

4.02

219

321

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1397

7558

2.70

142.09

3.5

2.4

—

estimate

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1326

6995

2.71

141.83

2.8

2.0

68.09

73.86

nmol/l

10.72

1249

6636

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

468

1364

3.92

139.64

3.7

5.5

237.30

246.65

u/l

0.50

444

1311

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

303

629

5.28

139.38

12.3

9.3

15.80

16.51

3.42

297

600

(3009343) pH of Capillary blood

217

328

7.09

138.30

3.6

2.9

7.41

7.42

2.29

191

278

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2633

20313

6.39

137.56

26.4

7.7

25.16

26.71

mg/l

1.58

2335

14736

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

126

100

13.15

130.49

1.8

1.3

31373.80

116.82

e6/l

0.51

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

125

13.31

130.41

1.8

1.2

27.40

7.33

e6/l

1.33

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

647

2427

3.17

129.46

3.0

2.4

1597.99

686.22

ng/l

1.65

539

2025

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

275

574

5.21

125.39

1.6

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

120

12.88

122.85

1.3

1.1

3.82

3.50

mmol/l

2.25

111

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

128

115

11.62

122.56

1.3

1.1

522.61

454.53

mg/l

0.55

122

110

(3023520) Reticulocytes [#/volume] in Blood

313

745

4.61

121.82

2.4

2.8

75.64

66.95

e9/l

2.08

193

530

(3020630) Protein [Mass/volume] in Serum or Plasma

271

575

5.11

121.16

2.2

3.1

67.44

66.58

g/l

0.79

251

542

(3000475) Leukocytes [#/volume] in Synovial fluid

20.01

120.32

1.7

1.2

13626.39

25338.52

e6/l

0.25

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

190

291

6.93

119.38

3.4

2.8

1.92

1.56

mmol/l

0.52

146

204

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2559

19948

4.47

116.83

23.3

7.6

94.87

89.70

ml/min/173m2

27.30

2409

17638

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

163

221

7.77

114.25

2.1

743.75

887.77

u/ml

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

242

495

5.26

112.68

9.5

6.4

24.63

24.28

mmol/l

0.57

235

466

(3044290) Cell count panel - Cerebral spinal fluid

116

103

11.71

111.86

1.8

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

117

152.57

111.06

2.5

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

204

365

5.95

109.82

5.3

2.9

58.04

45.60

7.26

195

360

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

466

1575

3.35

109.53

1.3

1.1

10.26

1.51

u/ml

1.99

139

675

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

291

710

4.46

109.43

1.7

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

185

303

6.47

108.88

4.5

4.0

812.07

464.16

iu/ml

0.28

(3004588) Protein electrophoresis panel - Serum or Plasma

204

379

5.73

105.49

2.0

2.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

171

269

6.71

104.61

1.9

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

206

392

5.59

103.79

1.9

1.8

1.45

1.32

g/l

0.94

169

326

(40768797) Stomach Pathology biopsy report

486

1743

3.17

103.13

1.3

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

108

160.41

102.93

2.5

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

186

325

6.06

102.52

3.0

2.6

2.28

2.52

index

0.16

100

172

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

787

3676

2.59

101.32

3.0

2.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

219

451

5.18

100.99

1.7

1.2

—

(3044941) Cell count panel - Synovial fluid

20.25

97.69

1.5

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

335

995

3.69

95.62

2.6

2.7

362.61

395.20

nmol/l

1.94

308

929

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2404

18708

3.08

95.18

36.2

10.3

13.83

13.28

67.52

2392

18347

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

216

465

4.95

94.49

3.8

2.4

1.42

1.14

mg/l

6.35

208

433

(3024666) Lithium [Moles/volume] in Serum or Plasma

115

128

9.33

94.48

14.0

16.3

0.59

0.65

mmol/l

1.22

103

117

(3029937) Albumin [Presence] in Urine by Test strip

819

4009

2.48

94.48

4.2

2.3

0.00

estimate

1.08

319

1377

(3015235) Bicarbonate [Moles/volume] in Capillary blood

135

184

7.66

94.05

3.2

2.4

24.99

24.64

mmol/l

0.37

135

177

(3021788) Differential panel - Synovial fluid

21.73

93.97

1.7

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

183

342

5.66

93.89

4.4

2.3

25.00

25.21

mmol/l

0.32

174

330

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

826

4084

2.45

92.99

3.2

2.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1459

9174

2.24

92.93

3.6

2.6

123.94

106.08

ug/l

2.11

1359

8808

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

14.72

92.30

1.6

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

109

117

9.65

92.01

16.1

12.7

1280.82

13693.06

u/ml

0.46

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

786

3816

2.48

91.95

1.4

1.2

2.21

2.17

u/ml

0.02

158

1157

(3019060) Gas panel - Arterial blood

207

441

4.99

91.63

7.0

5.1

—

(1616796) Gas panel - Central venous blood

122

153

8.29

91.18

4.4

2.9

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

162

280

6.08

90.17

3.3

2.6

2495.38

1784.00

titre

0.31

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

150

243

6.47

89.06

2.0

7.51

6.89

g/l

2.89

138

231

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

149

243

6.42

87.88

2.0

3.93

3.70

g/l

0.51

138

231

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

149

243

6.42

87.88

2.0

4.32

4.21

g/l

0.55

138

231

(3002179) Metamyelocytes/Leukocytes in Blood

313

939

3.63

87.76

5.0

4.5

0.62

0.86

1.06

133

284

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

137

205

6.98

87.72

2.0

2.2

0.55

1.12

g/l

0.72

121

181

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

108

123

9.09

87.14

2.6

2.9

145.19

153.54

nmol/l

0.28

112

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

176

342

5.43

86.46

1.2

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

710

3373

2.48

86.36

2.8

2.0

343.81

337.44

umol/l

0.81

636

3176

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

139

217

6.69

85.50

1.7

1.9

12.88

10.23

g/l

4.39

126

204

(3017181) Myelocytes/Leukocytes in Blood

320

997

3.50

84.58

5.3

4.6

0.61

1.07

2.48

132

296

(3025159) Blasts/Leukocytes in Blood

314

976

3.50

83.25

5.6

4.8

0.08

1.48

1.59

120

248

(3023420) DNA double strand Ab [Units/volume] in Serum

154

274

5.89

83.13

1.4

1.3

11.94

8.39

iu/ml

0.28

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

100

110

9.39

82.83

3.3

3.0

37.02

38.02

0.15

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

123

175

7.31

82.43

1.6

2.2

0.00

0.01

g/l

0.50

111

156

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

127

189

6.99

81.69

1.8

2.1

0.00

0.10

g/l

0.57

116

171

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

140

233

6.27

80.88

1.9

2.0

2.97

2.85

g/l

0.62

128

221

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

157

292

5.64

80.85

2.5

2.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

44.38

80.60

1.3

1.2

1.33

1.97

nmol/l

0.46

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

232

599

4.13

80.42

5.0

2.9

97.96

76.09

ng/l

2.88

214

544

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

116

164

7.34

78.15

1.6

2.1

0.00

g/l

-0.00

111

156

(3037121) Protein [Mass/volume] in Urine

187

418

4.72

77.98

4.7

4.5

326.48

306.13

mg/l

0.06

134

246

(3021440) Promyelocytes/Leukocytes in Blood

300

947

3.43

77.46

5.5

4.7

0.04

0.18

1.16

113

251

(3000494) Fungus identified in Specimen by Culture

478

1976

2.71

76.69

1.5

1.3

—

(3012501) Base excess in Blood by calculation

121

184

6.83

76.25

4.5

2.5

2.11

2.45

mmol/l

0.68

110

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

128

208

6.40

75.68

1.3

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

128

208

6.40

75.68

1.3

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

118

178

6.88

74.92

1.2

1.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2410

19512

2.74

74.39

5.5

3.0

6.11

5.44

mmol/l

57.33

2254

18399

(3029634) Reagin Ab [Titer] in Serum by VDRL

164

342

5.03

74.25

4.4

3.3

15.36

10.56

titre

0.14

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

160

329

5.10

73.62

2.3

1.8

1.51

3.92

ug/l

1.00

145

302

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

24.07

72.70

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

120

8.25

71.85

1.2

1.3

440.00

360.50

titre

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2695

23395

5.65

71.84

31.1

9.2

74.80

75.37

umol/l

0.34

2685

23055

(3023410) Appearance of Cerebral spinal fluid

12.84

71.02

2.2

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

506

2237

2.54

70.36

1.7

1.4

36516000.42

26802461.35

pmol/l

0.14

419

1970

(3022313) Gas panel - Capillary blood

121

201

6.25

69.97

3.3

3.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

138

262

5.49

69.42

2.9

2.6

0.27

0.28

iu/ml

0.19

129

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

15.84

68.41

2.5

2.4

239.33

205.00

ug/min

0.08

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

168

383

4.60

68.27

1.2

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

169

401

4.42

65.27

1.3

1.2

271.51

246.46

u/ml

0.48

123

281

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

13.19

64.91

2.5

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

191

500

4.03

64.74

3.2

2.2

3.52

3.50

g/l

0.05

185

475

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2690

23635

5.01

63.44

20.7

6.7

43.48

27.69

u/l

31.51

2668

23013

(3011648) Oxygen content in Venous blood

120

7.63

62.46

1.9

10.69

11.50

0.72

120

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

127

248

5.32

61.89

1.1

1.66

1.46

g/l

4.51

117

230

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

+∞

61.68

3.1

0.0

2.62

—

ug/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

10.54

60.69

1.1

39.86

26.54

iu/ml

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

27.72

60.25

4.7

1.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

104

174

6.17

59.68

2.4

4.2

53.19

46.09

mg/l

0.36

146

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

156

373

4.37

59.62

1.3

162.33

145.10

au/ml

0.95

108

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

245

801

3.26

59.36

4.9

3.2

1.21

1.23

mmol/l

2.34

219

676

(1761868) Lipid panel - Serum or Plasma

694

11349

0.48

58.93

3.2

2.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

103

174

6.11

58.53

2.4

4.2

41.76

41.44

mg/l

0.01

147

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

9.42

58.47

3.6

4.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2314

19024

2.28

57.89

6.6

2.7

38.37

35.54

mmol/mol

32.61

2188

18117

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

217

668

3.44

57.88

2.0

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

870

5150

2.00

57.69

3.2

2.0

0.00

0.03

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

159

400

4.15

56.81

6.6

5.0

2.29

1.74

3.74

150

367

(3017732) Neutrophils [#/volume] in Blood

383

1636

2.55

56.44

5.2

3.1

4.99

4.17

e9/l

0.94

334

1459

(3036489) Thrombin time

185

522

3.72

56.28

3.1

1.7

21.90

20.96

1.52

173

462

(3003181) Sodium [Moles/volume] in Urine

114

7.38

56.01

1.7

1.2

49.58

58.43

mmol/l

0.64

(40768441) Liver Pathology biopsy report

139

6.66

55.83

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

172

464

3.88

55.81

5.2

2.0

196.39

183.86

0.75

166

448

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

156

6.20

54.36

2.2

4.1

2.51

8.47

ratio

0.61

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

126

275

4.75

53.93

1.4

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

213

678

3.32

53.80

2.4

1.9

10.15

12.64

ug/l

0.42

190

619

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

302

1176

2.76

53.46

8.6

3.9

—

(40761535) Cells panel - Urine sediment

201

621

3.41

53.24

3.6

2.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

227

758

3.17

52.98

1.4

1.2

—

(21494755) Public health laboratory ask at order entry panel

143

4451

0.28

51.85

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

267

990

2.88

51.79

1.8

403.27

278.39

mu/l

3.56

222

900

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

110

223

5.09

51.35

1.5

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

8.73

51.28

2.2

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

462

2236

2.28

51.20

3.0

2.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

147

378

4.05

50.95

6.9

5.2

0.85

0.91

0.82

139

345

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

201

639

3.31

50.83

3.4

2.2

176.48

148.56

ng/l

0.36

181

564

(3000570) Elastase.pancreatic [Mass/mass] in Stool

124

281

4.57

50.67

1.4

1.3

255.99

276.67

ug/g

0.48

176

(3035947) Staphylolysin Ab [Units/volume] in Serum

12.40

50.50

1.2

1.1

5.40

2.60

iu/ml

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

396

1808

2.39

50.18

3.0

2.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

125

290

4.47

49.59

1.4

1.5

—

(40761536) Microorganisms panel - Urine sediment

291

1156

2.69

49.42

4.2

2.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

714

4130

1.98

49.32

7.2

3.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

189

5.28

47.35

1.4

1.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

11.05

46.90

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

179

4727

0.34

46.55

1.8

3.45

3.56

ratio

0.49

136

3527

(3006184) Hemoglobin [Mass/volume] in Capillary blood

105

227

4.77

45.44

2.7

2.0

129.91

132.53

g/l

0.43

174

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

10.82

45.34

3.0

2.3

0.60

0.61

mmol/l

0.17

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

264

1042

2.69

45.29

3.0

2.5

5986.84

7881.88

u/l

0.34

465

(3009214) Lutropin [Units/volume] in Serum or Plasma

210

740

2.99

44.52

1.5

8.02

8.66

u/l

0.31

146

603

(3000093) Morphology [Interpretation] in Blood Narrative

7.17

44.10

1.1

—

(36660697) Celiac disease serology panel - Serum

298

1268

2.51

43.79

1.2

1.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

260

1039

2.66

43.47

3.3

2.2

66.14

77.16

ml/min/173m2

2.89

106

390

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

9.26

42.20

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

10.62

41.12

1.0

—

(3017509) Phencyclidine [Presence] in Urine

11.51

40.50

4.6

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1000

6777

1.74

39.95

4.3

2.2

0.01

0.03

estimate

1.38

291

1250

(40760888) Immunoglobulin light chains.free panel - Serum

125

5.89

39.77

2.9

3.8

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

243

985

2.61

39.39

1.4

—

(3035933) Granulocytes/Leukocytes in Blood

113

290

4.02

39.24

4.6

2.9

54.38

58.43

2.74

113

290

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

13.38

39.13

3.0

4.9

5.14

12.54

ug/l

0.53

(3019832) Treponema pallidum Ab [Presence] in Serum

622

3676

1.89

39.08

2.3

1.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

114

297

3.96

38.78

1.2

1.1

0.28

0.89

u/ml

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1136

8023

1.70

38.74

2.0

1.6

1.52

1.33

mmol/l

7.66

1016

7202

(3047181) Lactate [Moles/volume] in Blood

115

302

3.93

38.69

7.3

5.6

1.32

1.27

mmol/l

0.15

105

262

(40759836) Histone Ab [Presence] in Serum by Immunoblot

9.34

38.34

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

9.15

37.77

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

199

745

2.80

37.67

2.5

2.8

4.50

4.54

pmol/l

0.22

167

670

(44790048) Parainfluenza type 2 nucleic acid detection

150

5.25

37.60

1.5

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

9.32

37.45

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

9.32

37.45

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

195

4.63

36.96

1.9

1.4

2.76

2.10

iu/l

0.77

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

131

3638

0.33

36.65

1.7

1.6

3.37

3.60

mmol/l

1.61

2404

(44806118) Parainfluenza type 4 nucleic acid detection

150

5.18

36.57

1.5

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

150

5.18

36.57

1.5

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

150

5.18

36.57

1.5

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

189

4.61

35.56

1.4

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

8.92

35.45

1.1

—

(3008295) Osmolality of Serum or Plasma

6.95

35.22

2.0

1.5

284.10

277.72

mosm/kgh2o

0.71

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

13.48

33.97

1.8

2.1

15.46

13.03

umol/l

0.58

(3045414) Leukocytes [Presence] in Urine

227

957

2.49

33.80

1.8

1.7

0.00

0.02

estimate

0.68

249

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

8.87

33.69

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

223

4.18

33.64

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

117

5.57

33.50

1.4

—

(3004809) Band form neutrophils/Leukocytes in Blood

164

4.74

32.98

2.7

3.5

1.86

2.07

0.10

150

(3018333) Ribosomal P Ab [Presence] in Serum

8.51

32.63

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

264

3.85

32.60

1.5

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

172

4.58

32.04

1.4

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

11.09

32.01

1.1

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

210

4.19

31.94

1.7

1.5

419.41

342.54

mu/l

0.57

174

(3006653) Thiamine [Moles/volume] in Blood

11.50

31.82

1.2

1.1

147.03

134.24

nmol/l

0.44

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

123

385

3.30

31.80

1.5

0.39

0.03

iu/ml

0.85

(3019225) pH of Specimen

218

929

2.46

31.68

3.9

3.0

7.37

7.36

0.57

174

673

(3006571) Granulocytes/Leukocytes in Synovial fluid

33.79

30.93

1.8

1.2

68.33

60.80

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

225

4.01

30.73

1.5

1.7

0.81

0.77

g/l

0.15

178

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

225

4.01

30.73

1.2

1.1

6.61

5.34

u/ml

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

131

5.06

30.57

1.4

—

(3008898) HLA-B27 [Presence]

114

349

3.36

30.54

1.1

1.0

—

(3037756) Immunofixation for Serum or Plasma

120

5.26

30.51

1.3

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

205

869

2.47

30.11

2.8

1.8

0.80

0.41

e6/l

0.46

193

825

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

11.60

30.05

3.2

1.6

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

45.53

29.65

1.2

1.1

—

mmol/l

—

(3008037) Lactate [Moles/volume] in Venous blood

179

4.34

29.60

3.8

2.2

1.57

1.39

mmol/l

0.78

172

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

10.80

28.67

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

110

5.27

28.15

1.5

1.4

28862.49

2392.39

e6/l

0.73

(3039000) Anion gap in Blood by calculation

215

3.90

27.68

8.9

6.9

11.05

11.18

mmol/l

0.11

186

(3018572) Chloride [Moles/volume] in Blood

215

3.90

27.68

8.9

6.9

104.21

105.04

mmol/l

0.61

186

(3017446) Testosterone [Moles/volume] in Serum or Plasma

429

2495

1.85

27.43

2.9

2.0

13.39

15.18

nmol/l

3.79

366

2362

(3028308) Erythrocytes [#/volume] in Pleural fluid

5.44

26.66

1.5

1.4

43803.03

25684.02

e6/l

0.40

(3040151) Glucose [Moles/volume] in Capillary blood

5.51

26.49

2.5

2.4

7.55

5.89

mmol/l

2.22

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

157

624

2.61

26.37

3.6

4.9

114.40

1927.66

u/ml

1.09

134

547

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

134

492

2.81

26.26

1.7

2.4

47.62

40.76

u/l

1.81

121

467

(3012441) Differential panel - Pleural fluid

5.45

26.19

1.5

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1804

0.21

26.00

1.1

0.61

0.65

ratio

—

175

(3007461) Platelets [#/volume] in Blood

2710

25498

3.30

25.75

43.0

11.8

239.61

251.77

e9/l

14.17

2675

24827

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

204

3.85

25.63

1.1

53.00

37.76

u/ml

—

(3045788) Cell count panel - Pleural fluid

5.34

25.61

1.6

1.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

28.66

25.37

1.8

1.2

27.44

17.73

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

182

791

2.39

25.27

2.3

2.2

31.62

19.55

au/ml

—

167

(3035941) MCH [Entitic mass]

2710

25526

3.26

25.14

42.7

11.8

30.26

30.20

1.04

2700

25231

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

314

3.23

25.08

1.1

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

8.94

25.07

1.4

12.39

7.96

ug/l

2.56

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2710

25530

3.25

25.06

42.8

11.8

90.55

90.02

7.58

2700

25237

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2710

25532

3.25

25.01

44.2

12.0

40.44

42.95

6.15

2699

25214

(3026361) Erythrocytes [#/volume] in Blood

2710

25537

3.24

24.90

42.8

11.8

4.52

4.66

e12/l

36.15

2667

24793

(3010813) Leukocytes [#/volume] in Blood

2710

25546

3.23

24.71

43.0

11.9

7.11

6.37

e9/l

44.29

2669

24784

(3000963) Hemoglobin [Mass/volume] in Blood

2710

25553

3.22

24.56

43.2

11.9

135.27

140.16

g/l

49.33

2698

25261

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

173

751

2.39

24.07

2.5

1.7

182.65

228.04

pmol/l

5.69

165

729

(3016038) Potassium [Moles/volume] in Urine

8.08

23.89

1.7

1.0

40.11

38.01

mmol/l

0.12

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

5.99

23.87

1.5

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

7.08

23.32

1.2

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

7.08

23.32

1.2

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

223

3.57

23.26

1.5

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

148

4.19

22.90

1.5

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

392

2336

1.79

22.87

2.4

3.1

130.22

127.91

ug/g

0.05

319

1940

(3013139) Helicobacter pylori Ag [Presence] in Stool

215

1045

2.15

22.83

1.3

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

6.07

22.48

1.2

1.0

319.21

141.71

iu/ml

1.98

(3023419) Bacteria identified in Sputum by Culture

105

4.83

22.46

1.9

2.4

—

(3051611) Lipemic interference index of Serum or Plasma

118

4.56

22.20

3.5

3.3

14.57

13.64

index

0.25

(3023487) Leukocytes [#/volume] in Peritoneal fluid

6.50

22.19

2.5

1.6

354.50

1695.38

e6/l

1.15

(3020876) Protein [Mass/time] in 24 hour Urine

5.45

21.66

1.6

2.4

2.31

1.42

g/24h

0.68

(3045424) Erythrocytes [Presence] in Urine

122

472

2.66

21.64

2.0

1.7

0.03

0.02

estimate

0.09

184

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

282

1547

1.92

21.37

3.4

5.8

8.70

57.70

ug/l

1.29

247

1219

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

179

3.75

21.29

1.3

1.1

46.89

40.76

u/l

0.10

147

(21494890) Protein electrophoresis panel - 24 hour Urine

6.48

20.92

1.3

2.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

111

417

2.73

20.86

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

110

416

2.71

20.41

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

109

412

2.71

20.25

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

209

1060

2.05

19.80

2.3

1.7

48.65

39.90

nmol/l

4.53

198

1045

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

5.89

19.63

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

346

2.84

19.52

1.5

2.4

13.36

10.34

mg/l

2.25

335

(3010144) Erythrocytes [#/volume] in Synovial fluid

16.84

19.15

1.8

1.0

32494.65

122251.30

e6/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

5.26

18.91

3.9

1.8

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

15.95

18.78

1.2

0.74

0.52

ratio

—

(3042733) HLA Ab [Presence] in Serum

8.13

18.76

2.5

3.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

220

3.29

18.74

1.3

1.2

2.87

1.89

u/ml

0.75

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

101

4.51

18.69

2.7

2.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

146

658

2.29

18.65

1.6

1.7

42.76

12.56

u/ml

1.08

246

(40768806) Pleura Pathology biopsy report

4.55

18.45

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

150

3.79

18.42

2.0

1.5

40.34

34.71

ng/l

0.13

150

(3044007) Cell count panel - Peritoneal fluid

5.98

18.23

3.0

1.6

—

(3017354) Segmented neutrophils/Leukocytes in Blood

117

4.16

17.96

2.4

3.9

51.77

54.82

0.32

(3011412) CD3 cells [#/volume] in Blood

4.52

17.52

3.5

2.5

1473.55

1118.80

e6/l

1.08

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

199

3.32

17.51

1.3

3.98

4.29

u/ml

0.08

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1939

17044

1.45

17.49

3.7

3.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

7.80

17.42

1.0

1.1

—

(4146454) Self-monitoring of blood glucose

28.97

17.40

3.3

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

4.56

17.28

1.2

65.31

50.09

u/l

1.30

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

276

2.92

17.04

1.4

1.3

16.11

29.16

u/l

2.80

234

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2266

20608

1.53

16.69

37.7

10.0

333.15

334.43

g/l

9.01

2260

20442

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

6.48

16.65

1.1

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

20.16

16.41

1.3

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

712

5271

1.47

16.35

3.8

2.0

0.00

0.02

estimate

3.43

300

1180

(40768446) Kidney Pathology biopsy report

11.71

16.02

1.7

1.8

—

(3000034) Microalbumin [Mass/volume] in Urine

6.19

15.93

3.4

1.8

95.22

28.25

mg/l

0.71

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

5.74

15.86

2.8

1.5

689.64

8275.20

e6/l

0.84

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

11.77

15.53

1.2

1.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

4.97

15.46

1.5

1.3

—

27.20

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

329

2.63

15.14

1.7

1.5

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

14.00

15.00

1.6

1.1

99.48

82.83

1.14

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

4.08

14.71

1.3

1.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

4.76

14.70

3.1

2.6

1.02

0.85

nmol/l

0.73

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

4.75

14.23

1.3

—

(4268621) Lupus anticoagulant assay

158

3.33

14.23

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2416

22473

1.56

14.10

5.5

3.6

2.63

3.00

mmol/l

82.78

2264

21502

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

660

4933

1.44

14.10

1.7

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

12.00

14.06

3.6

1.5

5.09

4.64

kpa

1.21

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

12.00

14.06

3.6

1.5

9.92

10.80

kpa

0.69

(3036782) Glucose [Moles/volume] in Pleural fluid

108

3.84

13.86

1.2

5.59

5.65

mmol/l

0.04

100

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

4.31

13.83

1.1

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

4.31

13.83

1.1

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

4.31

13.83

1.1

1.7

—

(3024932) HLA-DR beta [Type]

6.51

13.64

1.0

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

6.51

13.64

1.5

1.2

8.57

13.84

g/l

1.15

(3024471) HLA-A [Type]

6.09

13.39

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

25.86

13.36

2.4

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

325

2.50

12.95

1.1

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

3.89

12.79

2.8

3.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

234

2.78

12.77

1.2

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

154

3.22

12.73

1.8

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.95

12.71

1.3

1.9

—

(3003694) ABO and Rh group [Type] in Blood

821

6478

1.38

12.60

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

259

2.67

12.56

1.2

1.1

—

0.30

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

221

1324

1.73

12.44

1.3

1.4

23.31

26.09

iu/l

0.61

159

1099

(3042111) Morphology [Interpretation] in Bone marrow Narrative

184

2.97

12.26

1.5

2.2

—

(4195642) Thrombophilia screening test

219

2.78

12.03

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

178

2.96

11.72

5.1

2.7

9.41

6.80

pmol/l

1.24

178

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

246

3778

0.62

11.66

1.5

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

5.54

11.64

1.7

1.2

106.48

28.88

g/l

0.38

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

231

2.68

11.42

1.1

—

(4035726) Immunohistochemistry procedure

233

1449

1.66

11.42

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.83

11.19

1.1

1.2

—

(3000012) Reticulocyte production index

123

3.28

10.81

2.4

2.3

1.11

0.92

0.37

(3004716) Salmonella sp identified in Stool by Organism specific culture

176

1029

1.76

10.81

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

5.15

10.78

1.4

1.2

98.53

95.30

0.17

(3042631) Mycobacterium sp identified in Specimen

124

3.26

10.67

2.4

2.8

—

(40768443) Skin Pathology biopsy report

128

684

1.91

10.51

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

272

2.46

10.43

1.2

1.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

10.62

10.26

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

4.92

10.26

1.4

1.2

96.53

94.71

0.10

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

18.84

10.25

1.1

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

23.44

10.23

1.1

1.0

—

(3022145) Colonoscopy Study observation

285

1910

1.55

10.23

1.4

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

7.47

10.17

2.4

2.0

7.77

6.72

mmol/l

0.54

(4034850) Laboratory test

436

2.12

10.12

13.7

5.2

—

(3016228) CD19 cells/cells in Blood

5.29

10.11

4.8

1.9

8.35

8.05

0.07

(3025941) Bacteria identified in Stool by Culture

157

909

1.77

9.98

1.4

1.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

5.16

9.83

4.8

1.9

35.50

31.79

0.63

(3024891) Influenza virus A+B Ag [Presence] in Specimen

118

628

1.92

9.82

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

4.00

9.77

2.3

2.6

830.25

535.33

e6/l

0.75

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

288

2.36

9.68

2.7

2.6

37.39

19.33

iu/ml

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

264

2.42

9.63

1.3

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

112

3.24

9.58

1.4

1.3

0.19

0.17

nmol/l

0.35

(3005322) IgE [Units/volume] in Serum or Plasma

175

1058

1.70

9.55

1.3

160.55

338.86

u/ml

2.34

160

984

(3000330) Specific gravity of Urine by Test strip

107

557

1.96

9.51

3.8

2.1

1.02

ratio

0.06

489

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

139

2.98

9.46

1.4

1.3

0.18

0.15

nmol/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.88

9.40

1.1

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

17.58

9.39

1.1

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

21.76

9.34

1.2

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

21.76

9.34

1.1

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

109

575

1.93

9.33

2.3

2.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

109

3.24

9.30

1.1

1.3

0.46

0.44

g/l

0.11

(3027135) IgG subclass 1 [Mass/volume] in Serum

110

3.21

9.17

1.1

1.3

6.88

6.66

g/l

0.14

(3028192) IgG subclass 2 [Mass/volume] in Serum

110

3.21

9.17

1.1

1.3

3.17

3.47

g/l

0.34

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

13.70

9.17

1.1

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

13.70

9.17

1.1

1.0

4.59

4.52

mg/g

0.04

(3011985) Renin [Units/volume] in Plasma

164

2.77

9.13

1.6

79.66

67.69

mu/l

0.10

149

(3004616) Nuclear Ab [Presence] in Serum

3.52

9.06

1.3

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

9.05

9.02

1.1

1.0

—

(4024509) Urine culture

512

1.97

8.99

1.7

1.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

4.21

8.91

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1513

0.49

8.72

1.7

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

3.40

8.62

2.0

1.6

24.23

29.53

mg/l

0.24

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

239

1601

1.54

8.59

4.1

3.1

31.09

31.42

0.19

172

1105

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.78

8.58

2.8

3.9

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

+∞

8.33

1.1

0.0

—

mmol/l

—

(3013762) Body weight Measured

8.54

8.29

1.1

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.40

8.07

1.1

1.0

1623.68

1545.13

miu/ml

0.13

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

4.02

8.06

1.6

1.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

6.82

8.05

3.2

1.1

114.07

75.86

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

6.82

8.05

1.9

1.1

106.62

61.29

—

(3004451) EKG impression Narrative

6.29

8.00

1.4

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

159

2.67

7.97

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

13.05

7.87

2.6

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2358

22334

1.36

7.81

5.0

3.4

4.42

4.91

mmol/l

99.26

2214

21469

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

9.42

7.77

1.0

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

112

2.97

7.65

1.4

1.2

—

nmol/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

151

2.67

7.64

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

3.49

7.54

2.4

2.7

163.06

213.25

e6/l

0.80

(4062490) Immunoglobulin typing, IgG

108

2.99

7.50

1.1

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

8.37

7.31

1.1

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

+∞

7.29

2.9

0.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

3.24

7.24

3.1

2.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

15.77

7.22

1.0

1.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.49

7.17

1.2

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

607

0.29

7.15

1.4

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

369

2.00

7.14

2.3

2.4

13.05

7.02

umol/l

0.59

268

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.56

7.14

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

370

2.00

7.09

2.6

2.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

12.04

7.07

2.1

1.5

—

(3017569) Oxygen content in Arterial blood

6.03

7.06

2.9

2.4

15.69

15.64

0.02

(3001964) Herpes simplex virus Ag [Presence] in Specimen

5.62

7.05

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

452

1.88

6.87

1.8

—

(3025130) Human papilloma virus identified in Specimen

397

1.94

6.79

1.8

1.9

—

(3005570) Glucose [Moles/volume] in Urine

3.03

6.77

2.0

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

155

2.54

6.76

1.4

1.5

307.19

383.21

pmol/l

0.58

140

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.27

6.75

1.2

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

132

2.67

6.73

1.1

1.2

—

(3024263) Appearance of Synovial fluid

7.18

6.69

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

123

1957

0.61

6.66

1.4

1.6

1092.17

1066.91

mu/l

0.06

1667

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.72

6.63

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

212

2.29

6.63

1.8

1.9

5.83

5.90

mmol/24h

0.03

197

(40768804) Tissue Pathology biopsy report

900

7709

1.25

6.62

2.0

1.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.89

6.60

4.9

2.0

1.12

1.37

ratio

0.54

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.46

6.56

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

8.70

6.55

1.2

1.1

—

(3002256) Pathology report gross observation

318

2374

1.38

6.49

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

189

2.35

6.48

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

184

1244

1.51

6.38

1.2

119.65

153.02

u/ml

0.46

484

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

108

2.80

6.31

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

143

2.54

6.27

2.6

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

+∞

6.25

1.2

0.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

+∞

6.25

1.2

0.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

7.68

6.12

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

12.54

6.08

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

8.60

6.05

1.8

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2334

22266

1.30

5.89

4.9

3.4

1.32

1.47

mmol/l

54.92

2184

21323

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

3.54

5.88

1.0

1.2

—

100.00

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2196

20806

1.26

5.78

4.2

3.0

1.38

1.22

mmol/l

13.31

2038

19873

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

126

2.56

5.70

1.1

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

422

1.82

5.69

1.8

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.74

5.60

2.1

2.4

1.62

1.49

0.11

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

10.03

5.53

1.6

1.7

196.39

172.54

ug/l

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

+∞

5.21

4.2

0.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

126

2.48

5.20

1.1

1.5

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

8.36

5.06

2.4

1.5

3.00

3.21

—

(3014271) Vancomycin [Susceptibility]

10.03

5.02

3.1

2.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.41

5.02

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

125

2.42

4.80

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

125

2.42

4.80

1.1

1.5

—

(3013637) Mi-2 Ab [Presence] in Serum

9.02

4.78

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

9.02

4.78

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

9.02

4.78

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

9.02

4.78

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

5.22

4.76

1.0

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.43

4.74

1.4

1.3

551.80

112.48

nmol/24h

0.44

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

114

2.47

4.71

1.1

1.2

320.00

969.57

titre

—

(1761482) Bacteria [#/volume] in Urine by Culture

238

1.99

4.69

5.5

2.4

—

(3017704) Immunofixation for Urine

4.68

4.67

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.50

4.61

1.1

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.50

4.61

1.1

2.3

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

422

0.33

4.61

10.1

1.7

13.51

12.97

0.97

416

(3034426) Prothrombin time (PT)

3.35

4.60

1.2

1.3

32.69

27.62

1.24

(3022621) pH of Urine by Test strip

177

1270

1.42

4.59

2.3

1.7

6.05

6.16

0.99

120

713

(3045142) Bone marrow Pathology biopsy report

153

2.24

4.59

1.3

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

14.03

4.57

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

123

2.37

4.48

1.1

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.16

4.48

1.1

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

6.69

4.46

1.1

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

5.23

4.45

1.4

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

124

2.35

4.41

1.1

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

124

2.35

4.41

1.1

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.21

4.33

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.52

4.28

1.1

1.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

11.69

4.27

1.0

—

(3035880) pH of Pleural fluid

3.15

4.20

1.3

1.1

7.32

7.35

0.11

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.25

4.14

2.0

1.6

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

5.90

4.12

1.3

15.32

52.63

nmol/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.02

4.09

1.5

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

104

2.42

4.05

2.3

2.1

30.78

25.39

mg/l

0.34

(3044927) Protein electrophoresis panel - Urine

4.21

4.01

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1152

0.62

3.91

1.5

53.11

61.31

ug/l

1.11

966

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.27

3.90

1.1

2.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

950

0.59

3.83

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

811

0.56

3.81

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.84

3.79

1.1

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.84

3.79

1.1

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.84

3.79

1.1

2.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

8.77

3.77

1.3

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

12.02

3.76

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

148

1069

1.41

3.75

1.0

—

(3005033) Fetal Nuchal fold Thickness US

912

0.60

3.64

1.6

1.5

1.22

1.29

0.53

687

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

247

0.32

3.57

5.0

7.1

9.75

8.76

—

247

(40761995) Spermatozoa Progressive [#/volume] in Semen

247

0.32

3.57

2.5

3.6

31.88

46.79

—

247

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

470

1.59

3.53

1.4

1.5

0.24

0.46

nmol/l

3.13

374

(3047352) Trisomy 18 risk [Likelihood] in Fetus

928

0.61

3.52

1.6

1.5

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

10.02

3.49

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

147

2.05

3.36

1.9

1.7

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.84

3.35

1.2

146.67

170.96

mmol/24h

0.86

(3014891) Appearance of Pleural fluid

8.59

3.26

1.8

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

8.59

3.26

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

4.75

3.23

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.68

3.22

1.1

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.18

3.19

1.1

—

(3033099) Centromere Ab [Titer] in Serum

5.34

3.19

1.3

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.80

3.18

1.1

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1072

0.65

3.17

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

2.48

3.12

6.6

4.1

27.80

30.98

mu/l

0.14

(40757373) Influenza virus identified in Isolate

4.51

3.11

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.81

3.08

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1087

0.66

3.06

1.5

0.91

0.95

ratio

0.58

674

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1087

0.66

3.06

1.5

1.17

1.22

ratio

0.18

679

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1085

0.66

3.03

1.5

1.15

1.17

ratio

0.09

671

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

10.01

2.98

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

421

1.56

2.91

1.3

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

697

6220

1.16

2.88

3.6

4.0

1.96

2.26

ug/l

0.24

610

5812

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.68

2.87

1.0

—

(21494434) Karyotype in Bone marrow

102

2.17

2.86

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

137

1.98

2.80

1.4

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

8.34

2.75

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

6.01

2.70

1.3

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.15

2.64

2.5

1.8

—

(44813793) Dust mix specific IgE antibody measurement

106

2.08

2.62

1.2

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.61

2.57

2.3

3.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

261

2158

1.23

2.55

1.8

1.9

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

520

1.45

2.48

1.1

1.62

6.79

eliau/ml

—

124

(4281824) Cell count and differential, peritoneal fluid

202

1.74

2.48

1.5

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

103

2.05

2.41

1.2

0.57

1.78

u/ml

0.91

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.01

2.40

1.2

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

6.26

2.37

1.4

1.3

67.80

93.50

ug/l

—

(4212803) Bone marrow aspirate examination

6.26

2.37

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

4.13

2.36

1.1

1.2

300.82

177.94

mg/l

—

(3002619) Bacteria identified in Specimen by Culture

2.86

2.20

1.1

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

396

3454

1.17

2.19

1.6

1.5

—

(3047189) Immunofixation for 24 hour Urine

3.01

2.14

1.0

2.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

692

0.66

2.12

1.3

1.5

51.78

62.26

ug/l

0.99

692

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

454

1.44

2.12

2.2

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.51

2.05

1.4

2.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.01

2.04

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

4.01

2.04

4.2

2.0

41.55

42.75

g/l

—

(40768800) Prostate Pathology biopsy report

410

0.58

1.92

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

114

1.85

1.87

1.7

1.2

75.90

81.28

umol/l

0.49

114

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1087

0.75

1.87

1.7

1.8

—

(1002224) Polysomnography panel

126

999

1.27

1.85

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

238

1.56

1.81

1.1

2.36

3.02

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.76

1.79

1.6

1.5

—

(3028433) Virus identified in Specimen by Culture

2.50

1.74

1.2

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

103

1.85

1.71

3.5

4.2

84.74

121.33

nmol/l

0.72

103

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

564

0.67

1.70

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.58

1.61

1.4

1.2

389.40

361.86

umol/24h

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1248

0.79

1.58

1.3

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

141

0.42

1.52

2.7

4.4

22.40

53.45

u/ml

—

141

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.50

1.45

1.0

1.2

0.25

0.36

nmol/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.79

1.43

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.25

1.40

1.6

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

178

0.50

1.39

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.42

1.39

1.1

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.42

1.39

1.1

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

2.94

1.36

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.94

1.36

2.2

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.94

1.36

2.0

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

372

4117

0.89

1.34

2.4

2.5

0.55

0.81

ug/l

7.90

242

2002

(3001556) Androgen free Index in Serum or Plasma

2.50

1.30

1.5

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

2.78

1.28

7.2

5.5

0.16

0.28

umol/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

566

1.28

1.22

1.5

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

2.17

1.21

1.8

6.3

262.50

75.41

u/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

895

0.79

1.20

1.4

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.71

1.17

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.38

1.09

1.2

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.38

1.09

1.6

1.7

1.18

1.17

mmol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

456

0.72

1.08

1.1

6.83

4.00

u/ml

0.33

219

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

129

1.55

1.05

1.7

1.1

81.95

128.00

pmol/l

3.34

129

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

309

1.33

0.98

2.9

4.1

24.63

29.11

u/ml

0.24

303

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

481

0.75

0.98

1.3

2.76

3.84

ug/l

0.89

441

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.97

0.0

1.2

—

5.16

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

796

0.81

0.91

1.5

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

143

1.47

0.89

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.94

0.84

1.3

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

466

0.77

0.82

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.88

0.81

1.3

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

476

0.77

0.80

1.1

3.05

2.74

u/ml

0.06

255

(3047007) Chlamydophila sp Ab [Presence] in Serum

276

1.31

0.80

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

479

5094

0.93

0.79

3.4

3.2

24.15

20.83

2.34

152

1952

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

190

1.37

0.79

4.4

3.8

2.54

4.17

nmol/l

1.18

183

(40768795) Lymph node Pathology biopsy report

185

1.35

0.72

1.9

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

206

0.68

0.71

2.5

2.6

1881.28

673.29

pmol/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

543

0.81

0.70

1.1

0.45

1.97

u/ml

3.26

285

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.85

0.68

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

384

1.23

0.66

1.5

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

652

0.84

0.61

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

651

0.84

0.60

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

266

0.75

0.59

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

388

0.80

0.59

1.1

0.06

0.61

u/ml

1.14

115

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.45

0.59

1.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

307

0.78

0.55

1.2

1.3

177.55

208.71

pmol/l

0.49

307

(1617658) Protocol used for examination of sentinel lymph nodes

146

0.68

0.52

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

192

0.73

0.52

1.1

1.0

0.38

1.80

u/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

542

0.85

0.50

1.2

1.1

3.14

7.22

u/ml

1.90

314

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.52

0.48

1.0

1.6

166.24

67.91

ng/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

103

1.36

0.45

1.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.65

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.41

0.0

1.1

—

(44806420) Estimation of glomerular filtration rate

213

0.80

0.36

1.9

1.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

191

0.78

0.36

1.1

0.12

3.93

u/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1035

0.91

0.35

1.6

1.5

3.95

2.80

mg/l

0.96

631

(40758292) HTLV I+II Ab panel - Serum

1.25

0.29

1.4

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

521

0.90

0.27

1.1

0.36

1.33

u/ml

2.46

254

(40765096) Chromosome analysis panel by Banding

1.32

0.23

1.0

1.2

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.7

—

0.14

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.43

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

113

0.80

0.20

1.2

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

127

1.18

0.19

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.18

0.16

1.6

3.1

20.25

874.68

ug/l

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

204

0.88

0.16

1.2

1.4

26.98

46.77

nmol/l

1.35

186

(3051387) C reactive protein [Mass/volume] in Capillary blood

341

1.09

0.15

4.2

2.3

21.01

28.00

mg/l

0.43

219

(3020650) Glucose [Presence] in Urine

0.76

0.15

1.2

1.3

0.00

estimate

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

657

1.05

0.13

1.6

1.5

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

110

0.82

0.13

1.2

1.1

4.33

8.05

mm/h

—

110

(3025018) Bordetella pertussis Ab [Titer] in Serum

133

1.13

0.12

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

605

0.96

0.09

1.2

1.1

1.20

2.39

u/ml

1.00

328

(40768793) Breast Pathology biopsy report

429

1.05

0.09

1.4

1.3

—

(3006462) Nitrate [Presence] in Urine

0.83

0.08

1.8

2.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.83

0.07

1.0

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

187

0.96

0.01

1.6

2.1

25.14

26.79

ug/l

0.08

181

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

363

0.99

0.00

1.1

4.64

2.99

eliau/ml

0.24

232

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

4.5

—

109.50

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.2

—

36.83

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.57

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

5.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.99

-0.00

4.2

3.6

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.92

-0.00

3.2

2.1

182.22

192.96

u/l

—

(4211845) Urine protein measurement

0.96

-0.00

1.6

2.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.06

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

49.02

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: IBD_VIRAL_HEPATITIS – Viral hepatitis, IBD co-morbidity

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Viral hepatitis, IBD co-morbidity

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Viral hepatitis, IBD co-morbidity (IBD_VIRAL_HEPATITIS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints